10X Genomics Tax Provision Over Time
| TXG Stock | USD 15.90 0.42 2.71% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out 10X Genomics Performance and 10X Genomics Correlation. 10X |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 5.261 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) | Return On Equity (0.25) |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Tax Provision Analysis
Compare 10X Genomics and related stocks such as Twist Bioscience Corp, Fate Therapeutics, and Beam Therapeutics Tax Provision Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TWST | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 280 K | 242 K | 292 K | 382 K | (1.9 M) | (10.4 M) | 1.2 M | 560 K | 588 K |
| BEAM | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.4 M | 1000 K | 1.2 M |
| VCYT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (6.1 M) | 133 K | 374 K | 392.7 K |
| GH | 6 K | 6 K | 6 K | 6 K | 6 K | 6 K | 6 K | 7 K | 38 K | (1.9 M) | 379 K | 300 K | 1.1 M | 685 K | 719.2 K |
10X Genomics and related stocks such as Twist Bioscience Corp, Fate Therapeutics, and Beam Therapeutics Tax Provision description
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.My Equities
My Current Equities and Potential Positions
| 10X Genomics | TXG |
| Classification | Measuring and Control Equipment |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 15.9
Check out 10X Genomics Performance and 10X Genomics Correlation. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
10X Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.